G1 Therapeutics, Inc. (GTHX) Debt-to-equity % [USD] 2018 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
G1 Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2018 to 2024.
  • G1 Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 208 %, a 1.4% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 208 -2.96 -1.4% Mar 31, 2024
Q4 2023 212 +41.8 +24.6% Dec 31, 2023
Q3 2023 194 +62.4 +47.3% Sep 30, 2023
Q2 2023 206 +121 +143% Jun 30, 2023
Q1 2023 211 +155 +275% Mar 31, 2023
Q4 2022 170 +131 +339% Dec 31, 2022
Q3 2022 132 +102 +342% Sep 30, 2022
Q2 2022 84.9 +56.2 +196% Jun 30, 2022
Q1 2022 56.3 +29 +106% Mar 31, 2022
Q4 2021 38.7 +15.4 +65.8% Dec 31, 2021
Q3 2021 29.8 +11 +58.5% Sep 30, 2021
Q2 2021 28.6 +14.6 +103% Jun 30, 2021
Q1 2021 27.3 +17.5 +178% Mar 31, 2021
Q4 2020 23.4 +15.6 +203% Dec 31, 2020
Q3 2020 18.8 +13 +225% Sep 30, 2020
Q2 2020 14.1 +9.9 +237% Jun 30, 2020
Q1 2020 9.82 +5.59 +132% Mar 31, 2020
Q4 2019 7.72 +2.9 +60.2% Dec 31, 2019
Q3 2019 5.8 -0.47 -7.49% Sep 30, 2019
Q2 2019 4.17 Jun 30, 2019
Q1 2019 4.23 Mar 31, 2019
Q4 2018 4.82 Dec 31, 2018
Q3 2018 6.27 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.